To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Biotech has faced slim funding ...

Inspired by the Japanese art of kirigami, an MIT team has designed a technique that could transform flat panels into medical devices, habitats, and other objects without the use of tools. MIT ...

One of the hallmarks of Alzheimer’s disease is the clumping of proteins called Tau, which form tangled fibrils in the brain. The more severe the clumping, the more advanced the disease is. The Tau ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

Omnicom on Monday provided a deeper look at how its leadership and agency structure are changing following the close of its $13 billion-plus acquisition of rival Interpublic Group last week, according ...

“Directed self-assembly (DSA) of block copolymers (BCPs) has long been included in the semiconductor roadmap as a lithographic pathway to enable continued device scaling. Tremendous progress has been ...

MIT Sloan School of Management has been forced to withdraw a working paper which claimed AI played a “significant role” in most ransomware attacks after widespread criticism from experts. The study, ...

As AI becomes central to the enterprise, data engineers are stepping out from behind the scenes to help shape AI strategy and influence business decisions. In partnership withSnowflake As ...